Skip to main navigation Skip to search Skip to main content

A Phase IV, Prospective, Single-Arm, Open-Label Study to Measure Outcomes in Patients with Pulmonary Arterial Hypertension not on Active Treatment

Project: Research

Project Details

StatusFinished
Effective start/end date12/1/1405/24/18

Funding

  • Bayer Healthcare Pharmaceuticals Incorporated: $6,975.00